IMC Chicago LLC Sells 13,292 Shares of VanEck Pharmaceutical ETF $PPH

IMC Chicago LLC lessened its holdings in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) by 80.3% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 3,257 shares of the company’s stock after selling 13,292 shares during the quarter. IMC Chicago LLC’s holdings in VanEck Pharmaceutical ETF were worth $338,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Banque Cantonale Vaudoise lifted its holdings in VanEck Pharmaceutical ETF by 6.4% during the first quarter. Banque Cantonale Vaudoise now owns 1,907 shares of the company’s stock worth $198,000 after acquiring an additional 115 shares in the last quarter. CWM LLC increased its holdings in shares of VanEck Pharmaceutical ETF by 36.3% in the fourth quarter. CWM LLC now owns 511 shares of the company’s stock worth $53,000 after acquiring an additional 136 shares in the last quarter. IFP Advisors Inc increased its holdings in shares of VanEck Pharmaceutical ETF by 53.7% in the third quarter. IFP Advisors Inc now owns 438 shares of the company’s stock worth $40,000 after acquiring an additional 153 shares in the last quarter. Aspen Grove Capital LLC raised its position in shares of VanEck Pharmaceutical ETF by 0.7% during the fourth quarter. Aspen Grove Capital LLC now owns 26,209 shares of the company’s stock worth $2,704,000 after purchasing an additional 186 shares during the period. Finally, Farther Finance Advisors LLC raised its position in shares of VanEck Pharmaceutical ETF by 64.7% during the fourth quarter. Farther Finance Advisors LLC now owns 718 shares of the company’s stock worth $74,000 after purchasing an additional 282 shares during the period.

VanEck Pharmaceutical ETF Price Performance

NASDAQ:PPH opened at $109.88 on Friday. The business’s 50-day simple moving average is $105.51 and its 200-day simple moving average is $105.41. VanEck Pharmaceutical ETF has a fifty-two week low of $81.74 and a fifty-two week high of $112.58. The stock has a market capitalization of $943.87 million, a PE ratio of 20.21 and a beta of 0.46.

VanEck Pharmaceutical ETF Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, July 7th. Shareholders of record on Wednesday, July 1st were issued a dividend of $0.6248 per share. This represents a $2.50 annualized dividend and a yield of 2.3%. The ex-dividend date was Wednesday, July 1st.

VanEck Pharmaceutical ETF Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.